Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2017 / Cilt: 25 - Sayı: 3

The eighth staging system of non-small cell lung cancer and its practical implications

Küçük hücreli dışı akciğer kanserinde sekizinci evreleme ve uygulamadaki etkileri

Pages
484–498
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

New definitions of T, N, and M factors seem to better indicate the most optimal treatment option for an individual patient and to better predict the survival in patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Staging is an essential part of the approach to patients with lung cancer.
📊
Key Findings & Data:The current lung cancer staging system is the eighth edition of the tumor, node, and metastasis (TNM) classification, which was took effect in January 2017.
💡
Conclusion & Impact:New definitions of T, N, and M factors seem to better indicate the most optimal treatment option for an individual patient and to better predict the survival in patients.
🔬Design:Review & Systematic Survey
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Staging is an essential part of the approach to patients with lung cancer. The primary goal of the tumor classification is to correctly describe the anatomic extent of the disease. The anatomic extent of the tumor has a major impact on the treatment selection and prognosis. The general approach to patients with non-small cell lung cancer include mediastinal staging and non-thoracic staging methods, history and physical examination, imaging, minimally invasive techniques, and invasive surgical techniques. The current lung cancer staging system is the eighth edition of the tumor, node, and metastasis (TNM) classification, which was took effect in January 2017. In this article, staging methods and the definitions for current T, N, M descriptors and the stage groups in non-small cell lung cancer are reviewed. New definitions of T, N, and M factors seem to better indicate the most optimal treatment option for an individual patient and to better predict the survival in patients.

Özet

Evreleme akciğer kanserli hastalara yaklaşımın önemli bir kısmını oluşturmaktadır. Tümör sınıflandırmasının esas amacı hastalığın anatomik yaygınlığını doğru olarak ortaya koymaktır. Tümörün anatomik yaygınlığı tedavi seçimi ve prognoz üzerinde önemli bir etkiye sahiptir. Küçük hücreli dışı akciğer kanserinde hastalara genel yaklaşım; mediastenin evrelenmesi ve toraks dışı evreleme için evreleme yöntemlerini, öykü ve fizik muayene, görüntüleme, minimal invaziv teknikler ve invaziv cerrahi teknikleri içermektedir. Mevcut akciğer kanseri evreleme sistemi tümör, lenf nodu ve metastaz (TNM) sınıflamasının Ocak 2017’de kullanılmaya başlanan sekizinci baskısıdır. Bu makalede, küçük hücreli dışı akciğer kanserinde evreleme yöntemleri ile birlikte mevcut TNM tanımlayıcıları ve evre grupları için tanımlar gözden geçirildi. Değişen T, N ve M tanımlayıcılarının hastalarda tedavi seçeneklerini daha iyi işaret edebildiği ve sağkalımı daha doğru bir şekilde öngörebildiği görülmektedir.

🔖

Cite This Article

TURNA, A., YILMAZ, Ü., AK, G., KÖMÜRCÜOĞLU, B. E., YURT, S. (2022). The eighth staging system of non-small cell lung cancer and its practical implications. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 25 - Sayı: 3, 484–498. https://ajindex.com/articles/423953

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg 1995
  2. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975
  3. Jiang L, He J, Shi X, Shen J, Liang W, Yang C, et al. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis. Lung Cancer 2015
  4. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011
  5. Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, et al. The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016
  6. Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, et al. The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016
  7. Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A, et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol 2015
  8. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016
  9. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009
  10. Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002
  11. Qu X, Huang X, Yan W, Wu L, Dai K. A meta-analysis of 18FDG -PET-CT, 18FDG-PET, MRI and bone scin